RespireRx Pharmaceuticals Inc (RSPI)

[food4thought]

A buyout seems doubtful. The long term prospects look good enough to pursue with a partner. There should be a steady uptrend from here until a hurdle presents itself, funding or delays.

Was hoping for and expecting a higher base and volume today, but it is what it is. Sentiment has turned and interest should come. RD-1 data should seal the deal.

May I offer a big sigh of relief. Positive forward thinking has entered my brain, which has been absent as of late. Holding tight seems to be the logical play.